Cytos Biotechnology Reports Results from Phase IIa Study with
CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
...er risk for developingother allergic diseases like
rhinitis or asthma later in life. ADis characterized by a hypersensitivity reaction occurring in theskin that causes chronic inflammation and renders the skin dry,itchy and scaly. Irritants (e.g. wool, soap), allergens andemotional stress exacerbate disease s...
CYT003-QbG10 to treat allergy to be presented at the Congress of
the European Academy of Allergology and Clinical Immunology
(EAACI), June 9-13, 2007
...ositive results inpatients suffering from allergic
rhinitis due to grass pollenallergy and house dust mite allergy. CYT003-QbG10 is currentlybeing studied in clinical trials for the treatment of allergicrhinitis and atopic dermatitis. Please feel free to contact us at the address below should youwish to rece...
Separate Sets of Research Show Treatment Improved Quality of Life
in as Early as Three Weeks; Patient Adherence to Medication is
Multifactorial
...requentadverse events were headache (50% vs. 50%),
rhinitis (42% vs. 36%),diarrhea (35% vs. 50%), abdominal pain (32% vs. 44%) and flatulence(24% vs. 30%). Asacol is contraindicated in patients with hypersensitivity tosalicylates. Caution should be exercised when using Asacol inpatients with known renal dysf...
Positive results from placebo-controlled phase IIa study in
patients suffering from house dust mite allergy
...0 patientssuffering from mild to moderate allergic
rhinitis due to house dustmite allergy and assessed in a do... suffering from mild tomoderate perennial allergic
rhinitis due to house dust mite allergy. Upon entry into the study, the allergicstatus of the individual part...
ISTA Pharmaceuticals Announces Statistically Significant
Preliminary Results From its U.S. Phase II/III Clinical Study Of
Bepotastine
...use as a systemic drug inthe treatment of allergic
rhinitis and urticaria/pruritus in July2000 and January 2002, respectively, and is marketed by TanabeSeiyaku Co., Ltd. under the brand name TALION(R). TALION(R) wasco-developed by Tanabe Seiyaku and Ube Industries, Ltd., whodiscovered bepotastine. In 2001, Ta...
Inspire Announces Positive Results of Phase 2 Trial of Epinastine
Nasal Spray for Seasonal Allergic Rhinitis
...s who had a documentedhistory of seasonal allergic
rhinitis to mountain cedar pollen. Ofthe subjects randomize...(FDA) draft guidancedocument for seasonal allergic
rhinitis and includes runny nose,nasal congestion, itchy nose and sneezing. Results of the trialdemonstrated ...
Pacgen Announces Positive Results from Phase I/II Trial of Novel
Antifungal Drug
... treated with inhaledcorticosteroids for asthma or
rhinitis are also at risk.Oropharyngeal candidiasis infection can cause great discomfort, andif not treated, can spread from the primary site of infectionthrough the blood stream to cause a disseminated infection.Disseminated fungal infections are associated ...
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:
Potential Mitigating Factors Identified which Prevent Clear
Interpretation of Results
...asthe allergy season waned. Resolution of allergic
rhinitis couldimprove asthma symptoms and other measures of asthma control in allpatients independent of treatment. Our Phase 2b study was of a standard design generally used inthis setting, such that these issues were not anticipated. However,taken together...
Placebo-controlled Phase IIa Study with the Immunotherapeutic
CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in
Hay Fever Patients
...d sufferingfrom mild to moderate seasonal allergic
rhinitis due to grasspollen allergy. Upon entry into the st...m allergicdiseases (WHO, 2002). Seasonal allergic
rhinitis due to grass pollen(commonly known as hay fever) is very common and affects 15-20% ofthe European po...